• 1
    Powrie, F., Leach, M. W., Mauze, S., Caddle, L. B. and Coffman, R. L., Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 1993. 5: 14611471.
  • 2
    Bregenholt, S. and Claesson, M. H., Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease. Eur. J. Immunol. 1998. 28: 379389.
  • 3
    Claesson, M. H., Rudolphi, A., Kofoed, S., Poulsen, S. S. and Reimann, J., CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin. Exp. Immunol. 1996. 104: 491500.
  • 4
    Aranda, R., Sydora, B. C., McAllister, P. L., Binder, S. W., Yang, H. Y., Targan, S. R. and Kronenberg, M., Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J. Immunol. 1997. 158: 34643473.
  • 5
    Lantz, O. and Bendelac, A., An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD48 T cells in mice and humans. J. Exp. Med. 1994. 180: 10971106.
  • 6
    Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. and Van Kaer, L., NKT cells: what's in a name? Nat. Rev. Immunol. 2004. 4: 231237.
  • 7
    Exley, M., Garcia, J., Balk, S. P. and Porcelli, S., Requirements for CD1d recognition by human invariant Valpha24+ CD4CD8 T cells. J. Exp. Med. 1997. 186: 109120.
  • 8
    Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535562.
  • 9
    Burdin, N., Brossay, L., Degano, M., Iijima, H., Gui, M., Wilson, I. A. and Kronenberg, M., Structural requirements for antigen presentation by mouse CD1. Proc. Natl. Acad. Sci. USA 2000. 97: 1015610161.
  • 10
    Kawano, T., Tanaka, Y., Shimizu, E., Kaneko, Y., Kamata, N., Sato, H., Osada, H. et al., A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int. Immunol. 1999. 11: 881887.
  • 11
    Joyce, S., Woods, A. S., Yewdell, J. W., Bennink, J. R., De Silva, A. D., Boesteanu, A., Balk, S. P. et al., Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 1998. 279: 15411544.
  • 12
    Burdin, N. and Kronenberg, M., CD1-mediated immune responses to glycolipids. Curr. Opin. Immunol. 1999. 11: 326331.
  • 13
    Brigl, M. and Brenner, M. B., CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004. 22: 817890.
  • 14
    Brossay, L., Jullien, D., Cardell, S., Sydora, B. C., Burdin, N., Modlin, R. L. and Kronenberg, M., Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 1997. 159: 12161224.
  • 15
    Somnay-Wadgaonkar, K., Nusrat, A., Kim, H. S., Canchis, W. P., Balk, S. P., Colgan, S. P. and Blumberg, R. S., Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int. Immunol. 1999. 11: 383392.
  • 16
    Benlagha, K. and Bendelac, A., CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity. Semin. Immunol. 2000. 12: 537542.
  • 17
    Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y. et al., Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 16231626.
  • 18
    Saubermann, L. J., Beck, P., De Jong, Y. P., Pitman, R. S., Ryan, M. S., Kim, H. S., Exley, M. et al., Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 2000. 119: 119128.
  • 19
    Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagomez, D., Du, C., Stanic, A. K., Joyce, S. et al., Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 18011811.
  • 20
    Jahng, A. W., Maricic, I., Pedersen, B., Burdin, N., Naidenko, O., Kronenberg, M., Koezuka, Y. and Kumar, V., Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 17891799.
  • 21
    Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 10571062.
  • 22
    Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T. et al., The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 10521056.
  • 23
    Sonoda, K. H., Taniguchi, M. and Stein-Streilein, J., Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J. Immunol. 2002. 168: 20282034.
  • 24
    Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S. and Strober, W., Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002. 17: 629638.
  • 25
    Margalit, M., Ilan, Y., Ohana, M., Safadi, R., Alper, R., Sherman, Y., Doviner, V. et al., Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes. Bone Marrow Transplant. 2005. 35: 191197.
  • 26
    Wirtz, S., Becker, C., Blumberg, R., Galle, P. R. and Neurath, M. F., Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J. Immunol. 2002. 168: 411420.
  • 27
    Mudter, J., Wirtz, S., Galle, P. R. and Neurath, M. F., A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis. Pathobiology 2002. 70: 170176.
  • 28
    Farkas, S. A., Hornung, M., Sattler, C., Steinbauer, M., Anthuber, M., Obermeier, F., Herfarth, H. et al., Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis. Eur. Surg. Res. 2005. 37: 115122.
  • 29
    Kojouharoff, G., Hans, W., Obermeier, F., Mannel, D. N., Andus, T., Scholmerich, J., Gross, V. and Falk, W., Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 1997. 107: 353358.
  • 30
    Wirtz, S. and Neurath, M. F., Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int. J. Colorectal Dis. 2000. 15: 144160.
  • 31
    Chen, L., Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 2004. 4: 336347.
  • 32
    Podolsky, D. K., Inflammatory bowel disease. N. Engl. J. Med. 2002. 347: 417429.
  • 33
    Fiocchi, C., Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998. 115: 182205.
  • 34
    Fiocchi, C., From immune activation to gut tissue injury: the pieces of the puzzle are coming together. Gastroenterology 1999. 117: 12381241.
  • 35
    Powrie, F., Correa-Oliveira, R., Mauze, S. and Coffman, R. L., Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 1994. 179: 589600.
  • 36
    Hollander, G. A., Simpson, S. J., Mizoguchi, E., Nichogiannopoulou, A., She, J., Gutierrez-Ramos, J. C., Bhan, A. K. et al., Severe colitis in mice with aberrant thymic selection. Immunity 1995. 3: 2738.
  • 37
    Page, M. J., Poritz, L. S., Tilberg, A. F., Zhang, W. J., Chorney, M. J. and Koltun, W. A., CD1d-restricted cellular lysis by peripheral blood lymphocytes: relevance to the inflammatory bowel diseases. J. Surg. Res. 2000. 92: 214221.
  • 38
    Pellicci, D. G., Hammond, K. J., Coquet, J., Kyparissoudis, K., Brooks, A. G., Kedzierska, K., Keating, R. et al., DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J. Immunol. 2005. 175: 44164425.
  • 39
    Yue, S. C., Shaulov, A., Wang, R., Balk, S. P. and Exley, M. A., CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12. Proc. Natl. Acad. Sci. USA 2005. 102: 1181111816.
  • 40
    Colgan, S. P., Hershberg, R. M., Furuta, G. T. and Blumberg, R. S., Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl. Acad. Sci. USA 1999. 96: 1393813943.
  • 41
    De Libero, G. and Mori, L., Recognition of lipid antigens by T cells. Nat. Rev. Immunol. 2005. 5: 485496.
  • 42
    Hava, D. L., Brigl, M., van den Elzen, P., Zajonc, D. M., Wilson, I. A. and Brenner, M. B., CD1 assembly and the formation of CD1-antigen complexes. Curr. Opin. Immunol. 2005. 17: 8894.
  • 43
    Zhou, D., Mattner, J., Cantu, C. III, Schrantz, N., Yin, N., Gao, Y., Sagiv, Y. et al., Lysosomal glycosphingolipid recognition by NKT cells. Science 2004. 306: 17861789.
  • 44
    Van Kaer, L. and Joyce, S., Innate immunity: NKT cells in the spotlight. Curr. Biol. 2005. 15: R429R431.
  • 45
    Greenwald, R. J., Freeman, G. J. and Sharpe, A. H., The B7 family revisited. Annu. Rev. Immunol. 2005. 23: 515548.
  • 46
    Kanai, T., Totsuka, T., Uraushihara, K., Makita, S., Nakamura, T., Koganei, K., Fukushima, T. et al., Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 2003. 171: 41564163.
  • 47
    Hornung, M., Lindemann, D., Kraus, C., Peters, A. and Berberich, I., The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IGM-induced growth arrest. Eur. J. Immunol. 1998. 28: 38123823.
  • 48
    Schofield, L., McConville, M. J., Hansen, D., Campbell, A. S., Fraser-Reid, B., Grusby, M. J. and Tachado, S. D., CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999. 283: 225229.
  • 49
    Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H. et al., CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997. 278: 16261629.
  • 50
    Obermeier, F., Dunger, N., Strauch, U. G., Grunwald, N., Herfarth, H., Scholmerich, J. and Falk, W., Contrasting activity of cytosine-guanosine dinucleotide oligonucleotides in mice with experimental colitis. Clin. Exp. Immunol. 2003. 134: 217224.
  • 51
    Yamamoto, M., Fujihashi, K., Beagley, K. W., McGhee, J. R. and Kiyono, H., Cytokine synthesis by intestinal intraepithelial lymphocytes. Both gamma/delta T cell receptor-positive and alpha/beta T cell receptor-positive T cells in the G1 phase of cell cycle produce IFN-gamma and IL-5. J. Immunol. 1993. 150: 106114.
  • 52
    Overbergh, L., Valckx, D., Waer, M. and Mathieu, C., Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 1999. 11: 305312.